scanX
Marksans Pharma
add_icon

Marksans Pharma

274.60
+3.15
(1.16%)
Market Cap
12,447.30 Cr
PE Ratio
29.28
Volume
8,48,775.00
Day High - Low
277.80 - 271.00
52W High-Low
281.60 - 155.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
12,447.30 Cr
EPS
9.22
PE Ratio
29.28
PB Ratio
4.07
Book Value
66.71
EBITDA
683.30
Dividend Yield
0.33 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
13.76
Debt to Equity
0.12
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Marksans Pharma AGM Notice Published5 days ago
Marksans Pharma published the notice for its 34th Annual General Meeting in Business Standard and Lakshadeep on August 6, 2026, as per SEBI regulations.
neutral
Marksans Pharma files FY26 BRSR report7 days ago
Marksans Pharma Limited submitted its Business Responsibility and Sustainability Report for FY26 to stock exchanges, detailing ESG metrics, governance structures, and operational sustainability initiatives.
neutral
Marksans Pharma Q1FY27 Earnings Call Schedule7 days ago
Marksans Pharma Ltd to host its Q1FY27 earnings conference call on August 13, 2026, at 4:30 PM IST. Management will discuss unaudited standalone and consolidated financial results.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,936.10
#1 4,64,535.24
38.67
#1 61,673.90
12.69
#1 11,565
26.53
51.77
Divis Laboratories
8,478.00
2,25,064.26
75.10
11,067.00
13.95
2,568
65.50
73.18
Torrent Pharmaceuticals
4,849.50
1,84,459.39
86.72
13,886.20
20.34
2,138
3.28
51.57
Zydus Life Science
1,176.00
1,18,333.12
21.82
27,657.90
17.64
5,026
7.82
50.30
Cipla
1,460.70
1,18,001.97
35.15
29,044.60
2.24
3,870
-39.18
57.39
Lupin
2,269.30
1,03,759.78
#1 18.74
29,038.90
#1 26.75
5,356
16.00
35.94
Dr Reddys Laboratories
1,200.90
1,00,235.41
30.34
35,058.60
3.90
4,158
-69.10
35.65
Mankind Pharma
2,422.40
1,00,044.15
48.70
14,636.40
14.85
1,938
29.13
43.44
Laurus Labs
1,844.20
99,560.35
92.47
6,867.80
22.01
890
#1 123.93
79.60
Aurobindo Pharma
1,652.00
95,052.43
25.76
34,145.20
5.56
3,503
25.21
63.22
Growth Rate
Revenue Growth
12.80 %
Net Income Growth
9.80 %
Cash Flow Change
121.68 %
ROE
-10.47 %
ROCE
-6.05 %
EBITDA Margin (Avg.)
1.17 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
171
210
256
217
210
187
187
215
192
221
274
219
199
239
268
249
257
247
264
288
335
331
360
355
336
355
370
375
433
450
467
498
497
510
550
591
577
606
642
710
724
626
742
775
891
Expenses
132
160
204
187
206
173
180
188
177
192
249
190
195
200
232
212
232
213
223
240
266
261
273
267
235
272
301
305
354
361
372
403
376
398
417
453
450
462
495
543
582
520
576
594
661
EBITDA
39
50
51
31
4
14
7
27
15
29
25
29
4
39
36
36
25
35
41
47
69
70
87
88
101
83
69
70
79
89
94
94
121
112
133
138
126
143
147
167
142
106
166
181
231
Operating Profit %
23 %
24 %
20 %
14 %
2 %
7 %
0 %
12 %
4 %
13 %
9 %
13 %
2 %
15 %
14 %
15 %
6 %
13 %
13 %
16 %
21 %
21 %
23 %
25 %
29 %
22 %
17 %
16 %
15 %
17 %
18 %
16 %
23 %
20 %
21 %
23 %
20 %
22 %
23 %
20 %
18 %
16 %
20 %
21 %
23 %
Depreciation
4
5
6
10
8
5
6
12
8
7
7
6
6
6
6
5
6
5
5
7
10
7
19
9
1
8
7
9
21
11
14
13
14
14
18
22
21
20
20
21
23
23
27
24
24
Interest
1
3
3
2
2
1
1
2
2
2
3
2
4
2
3
2
2
2
3
2
2
2
2
2
3
1
2
1
5
2
3
2
2
2
2
3
5
3
3
3
3
6
6
6
6
Profit Before Tax
36
45
43
19
0
7
-0
13
-1
20
15
21
-6
30
28
30
17
28
34
38
58
61
66
78
97
75
60
60
53
76
78
79
104
97
114
113
100
120
125
143
116
77
133
151
200
Tax
10
13
7
-0
4
2
-1
2
2
5
4
4
1
6
7
4
7
5
8
9
15
12
15
19
18
12
14
12
23
16
18
17
22
26
30
30
23
31
27
38
25
18
34
37
51
Net Profit
26
32
36
19
-4
5
1
12
-3
14
10
18
-7
25
21
25
10
23
26
30
43
49
51
59
80
63
46
48
30
60
60
62
83
70
84
83
78
89
98
105
91
58
99
114
149
EPS in ₹
0.61
0.77
0.85
0.44
-0.14
0.11
0.02
0.24
0.00
0.33
0.23
0.41
-0.17
0.58
0.48
0.60
0.21
0.52
0.63
0.71
1.00
1.20
1.21
1.42
1.93
1.51
1.11
1.20
0.69
1.46
1.52
1.56
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2.00
1.29
2.17
2.50
3.27
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
676
722
752
732
804
903
1,229
1,640
2,190
2,681
3,240
3,861
Fixed Assets
166
270
267
279
270
303
309
428
486
776
982
1,044
Current Assets
509
440
484
451
531
594
903
1,201
1,675
1,863
2,204
2,723
Capital Work in Progress
0
0
0
0
0
0
12
3
10
9
27
59
Investments
0
0
0
0
0
0
0
0
1
27
1
0
Other Assets
510
453
485
453
534
600
908
1,209
1,694
1,869
2,230
2,758
Total Equity & Liabilities
676
722
752
732
804
903
1,229
1,640
2,190
2,681
3,240
3,861
Current Liabilities
286
259
296
235
233
229
299
356
341
390
477
527
Non Current Liabilities
2
0
16
17
18
25
25
61
84
205
273
281
Total Equity
388
463
440
480
553
649
905
1,223
1,765
2,086
2,489
3,053
Reserve & Surplus
326
401
393
430
502
595
846
1,068
1,700
2,020
2,422
2,978
Share Capital
53
53
41
41
41
41
41
41
45
45
45
45
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
138
-150
-10
15
-7
60
119
94
176
21
93
138
Investing Activities
-33
-123
-21
-39
-14
-60
-45
-84
-259
-141
-49
-249
Operating Activities
155
31
14
50
27
233
179
99
237
230
207
458
Financing Activities
17
-58
-4
3
-21
-114
-15
80
198
-69
-65
-71
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
48.25 %
48.25 %
48.25 %
48.25 %
48.25 %
48.25 %
48.60 %
49.00 %
43.80 %
43.85 %
43.85 %
43.85 %
43.85 %
43.85 %
43.87 %
43.87 %
43.87 %
43.87 %
43.87 %
43.87 %
43.87 %
43.87 %
43.87 %
FIIs
1.00 %
0.59 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.88 %
10.88 %
10.88 %
10.88 %
10.88 %
15.57 %
18.60 %
21.31 %
21.96 %
22.20 %
19.88 %
16.92 %
8.12 %
16.76 %
17.47 %
DIIs
0.09 %
0.34 %
0.34 %
0.34 %
0.46 %
0.95 %
0.95 %
0.96 %
0.87 %
1.46 %
3.65 %
3.15 %
3.82 %
5.17 %
3.75 %
4.10 %
4.30 %
4.56 %
5.50 %
5.28 %
5.91 %
6.57 %
6.19 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.15 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
41.50 %
41.71 %
42.41 %
42.47 %
41.36 %
40.77 %
39.76 %
39.69 %
35.19 %
34.42 %
32.36 %
32.12 %
30.80 %
30.91 %
29.47 %
26.77 %
26.24 %
25.77 %
26.75 %
29.53 %
28.98 %
28.33 %
28.05 %
Others
9.15 %
9.11 %
9.00 %
8.94 %
9.78 %
10.04 %
10.69 %
10.34 %
9.25 %
9.39 %
9.25 %
10.00 %
10.64 %
4.49 %
4.31 %
3.95 %
3.63 %
3.59 %
4.00 %
4.40 %
13.11 %
4.45 %
4.42 %
No of Share Holders
0
1,35,271
1,88,888
2,01,451
2,14,998
2,20,090
2,21,359
2,17,743
2,13,123
1,98,382
1,88,447
2,07,937
2,37,377
2,54,699
2,35,500
2,48,845
2,59,813
2,57,273
2,56,221
2,65,788
2,55,153
2,46,279
2,46,635

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.05 0.05 0.05 0.1 0.25 0.25 0.5 0.6 0.8 0.9
Dividend Yield (%) 0.16 0.2 0.36 0.2 0.55 0.34 0.33 0.27 0.51 0.33

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 27 Aug 2026 267.20 271.45
20 Aug 2026 DIVIDEND Dividend
₹ 0.90 /share
 20 Aug 2026 220.26 271.45
12 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2026 258.60 271.45
17 Sept 2021 DIVIDEND Dividend
₹ 0.25 /share
 15 Sept 2021 73.95 71.05
23 Aug 2022 DIVIDEND Dividend
₹ 0.25 /share
 19 Aug 2022 46.70 50.80
07 Jun 2023 DIVIDEND Dividend
₹ 0.50 /share
 07 Jun 2023 75.73 89.51
17 Sept 2024 DIVIDEND Dividend
₹ 0.60 /share
 17 Sept 2024 169.55 293.85
24 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 24 Sept 2024 209.01 314.54
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Nov 2024 266.10 288.60
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 11 Feb 2025 259.15 267.40
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 19 May 2025 225.54 241.40
01 Aug 2025 DIVIDEND Dividend
₹ 0.80 /share
 01 Aug 2025 241.40 227.80
08 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 08 Aug 2025 256.75 214.35
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 237.25 210.08
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 Nov 2025 180.20 196.92
05 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Feb 2026 178.86 177.16
26 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 26 May 2026 203.28 220.26

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Business Responsibility and Sustainability Reporting (BRSR)7 days ago
Reg. 34 (1) Annual Report.7 days ago
Shareholders Annual General Meeting To Be Held On August 27 20267 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
Board Meeting Intimation for Board Meeting Intimation For Declaration Of Quarterly Results For The Quarter Ended June 30 2026Jul 31, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2026
Announcement Under Regulation 30 (LODR)- UpdatesJul 20, 2026
DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"Jul 17, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 08, 2026
Announcement under Regulation 30 (LODR)-Date of payment of DividendJul 03, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 03, 2026
The Annual General Meeting Of The Marksans Pharma Limited Is Scheduled To Be Held On 27 August 2026.Jul 03, 2026
The Board Fixed 20 August 2026 As The Record Date For Ascertaining The Members Of The Company For Payment Of Dividend.Jul 03, 2026
Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Annual General Meeting Related MattersJul 03, 2026
Closure of Trading WindowJun 26, 2026
UpdatesJun 26, 2026
DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"Jun 23, 2026
Announcement Under Regulation 30 (LODR)- UpdatesJun 16, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJun 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2026
DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"Jun 02, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
Corporate Action-Board approves DividendMay 26, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 26, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 26, 2026
Audited Financial Results For The Quarter And Year Ended 31 March 2026May 26, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 26 May 2026May 26, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2026
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results And To Consider Recommendation Of Dividend If Any For The Financial Year Ended March 31 2026May 12, 2026
Compliances-Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations 2018Apr 09, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2026
Closure of Trading WindowMar 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 12, 2026
Intimation Regarding Opening Of Special Window For Re-Lodgment Of Transfer Requests Of Physical SharesMar 11, 2026
Investec India Promoter & Founder Conference 2026Mar 10, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025Feb 05, 2026
Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025Feb 05, 2026

Technical Indicators

RSI(14)
Neutral
57.72
ATR(14)
Less Volatile
9.87
STOCH(9,6)
Overbought
87.05
STOCH RSI(14)
Overbought
94.16
MACD(12,26)
Bullish
1.01
ADX(14)
Weak Trend
20.08
UO(9)
Bearish
56.00
ROC(12)
Uptrend And Accelerating
10.30
WillR(14)
Overbought
-13.59
Bearish
5
Neutral
2
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104